Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes

Show full item record



Permalink

http://hdl.handle.net/10138/314772

Citation

Latorre , J , Ortega , F J , Liñares-Pose , L , Moreno-Navarrete , J M , Lluch , A , Comas , F , Oliveras-Cañellas , N , Ricart , W , Höring , M , Zhou , Y , Liebisch , G , Nidhina Haridas , P A , Olkkonen , V M , López , M & Fernández-Real , J M 2020 , ' Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes ' , EBioMedicine , vol. 53 , 102697 . https://doi.org/10.1016/j.ebiom.2020.102697

Title: Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes
Author: Latorre, Jèssica; Ortega, Francisco J.; Liñares-Pose, Laura; Moreno-Navarrete, José M.; Lluch, Aina; Comas, Ferran; Oliveras-Cañellas, Núria; Ricart, Wifredo; Höring, Marcus; Zhou, You; Liebisch, Gerhard; Nidhina Haridas, P.A.; Olkkonen, Vesa M.; López, Miguel; Fernández-Real, José M.
Contributor: University of Helsinki, Medicum
Date: 2020-03
Language: eng
Number of pages: 16
Belongs to series: EBioMedicine
ISSN: 2352-3964
URI: http://hdl.handle.net/10138/314772
Abstract: Background: While the impact of metformin in hepatocytes leads to fatty acid (FA) oxidation and decreased lipogenesis, hepatic microRNAs (miRNAs) have been associated with fat overload and impaired metabolism, contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Methods: We investigated the expression of hundreds of miRNAs in primary hepatocytes challenged by compounds modulating steatosis, palmitic acid and compound C (as inducers), and metformin (as an inhibitor). Then, additional hepatocyte and rodent models were evaluated, together with transient mimic miRNAs transfection, lipid droplet staining, thin-layer chromatography, quantitative lipidomes, and mitochondrial activity, while human samples outlined the translational significance of this work. Findings: Our results show that treatments triggering fat accumulation and AMPK disruption may compromise the biosynthesis of hepatic miRNAs, while the knockdown of the miRNA-processing enzyme DICER in human hepatocytes exhibited increased lipid deposition. In this context, the ectopic recovery of miR-30b and miR-30c led to significant changes in genes related to FA metabolism, consistent reduction of ceramides, higher mitochondrial activity, and enabled b-oxidation, redirecting FA metabolism fromenergy storage to expenditure. Interpretation: Current findings unravel the biosynthesis of hepatic miR-30b and miR-30c in tackling inadequate FA accumulation, offering a potential avenue for the treatment of NAFLD. Funding: Instituto de Salud Carlos III (ISCIII), Govern de la Generalitat (PERIS2016), Associacio Catalana de Diabetis (ACD), Sociedad Espanola de Diabetes (SED), Fondo Europeo de Desarrollo Regional (FEDER), Xunta de Galicia, Ministerio de Economia y Competitividad (MINECO), "La Caixa" Foundation, and CIBER de la Fisiopatologia de la Obesidad y Nutricion (CIBEROBN). (c) 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Subject: 3111 Biomedicine
MicroRNAs
AMPK
Hepatocytes
Fatty acid homeostasis
Steatosis
METFORMIN
NAFLD
CHOLESTEROL
DE-NOVO LIPOGENESIS
FATTY LIVER-DISEASE
TRANSCRIPTION
ATHEROSCLEROSIS
METABOLISM
HIGH-THROUGHPUT QUANTIFICATION
MOLECULAR-MECHANISMS
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S2352396420300724_main.pdf 6.884Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record